These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6148621)

  • 1. Cimetidine or parietal-cell vagotomy in patients with juxtapyloric ulcers.
    Ström M; Bodemar G; Lindhagen J; Sjödahl R; Walan A
    Lancet; 1984 Oct; 2(8408):894-7. PubMed ID: 6148621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of short- and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion.
    Ström M; Berstad A; Bodemar G; Walan A
    Scand J Gastroenterol; 1986 Jun; 21(5):521-30. PubMed ID: 3092344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should it be parietal cell vagotomy or selective vagotomy-antrectomy for treatment of duodenal ulcer? A progress report.
    Jordan PH; Thornby J
    Ann Surg; 1987 May; 205(5):572-90. PubMed ID: 3555364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal gastric vagotomy versus long-term maintenance treatment with cimetidine for chronic duodenal ulcer: a prospective randomised trial.
    Gear MW
    Br Med J (Clin Res Ed); 1983 Jan; 286(6359):98-9. PubMed ID: 6401510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine treatment of recurrent ulcer after proximal gastric vagotomy.
    Berstad A; Aadland E; Bjerke K
    Scand J Gastroenterol; 1981; 16(7):891-6. PubMed ID: 7034163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforated pyloroduodenal ulcers. Long-term results with omental patch closure and parietal cell vagotomy.
    Jordan PH; Thornby J
    Ann Surg; 1995 May; 221(5):479-86; discussion 486-8. PubMed ID: 7748029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective controlled vagotomy trial for duodenal ulcer: primary results, sequelae, acid secretion, and recurrence rates two to five years after operation.
    Christiansen J; Jensen HE; Ejby-Poulsen P; Bardram L; Henriksen FW
    Ann Surg; 1981 Jan; 193(1):49-55. PubMed ID: 7006528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for parietal cell vagotomy without drainage in gastrointestinal surgery.
    Jordan PH
    Ann Surg; 1989 Jul; 210(1):29-41. PubMed ID: 2742412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parietal cell vagotomy or cimetidine maintenance therapy for duodenal ulcer? A prospective controlled trial.
    Harling H; Balslev I; Bentzen E
    Scand J Gastroenterol; 1985 Aug; 20(6):747-50. PubMed ID: 3898350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy.
    Feldman M; Richardson CT
    Gastroenterology; 1986 Mar; 90(3):540-4. PubMed ID: 3943686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified sham feeding test after parietal cell vagotomy for juxtapyloric ulcer disease in patients with and without recurrent ulcers.
    Ström M; Bodemar G; Lindhagen J; Sjödahl R; Walan A
    Scand J Gastroenterol; 1987 Apr; 22(3):279-88. PubMed ID: 3296133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cimetidine treatment of recurrent ulcer after vagotomy.
    Thomsen F; Kjaergaard J; Jensen HE
    Acta Chir Scand; 1980; 146(1):35-9. PubMed ID: 7376781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
    Marks IN; Lucke W; Wright JP; Girdwood AH
    J Clin Gastroenterol; 1981; 3(Suppl 2):163-5. PubMed ID: 7033353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duodenal, prepyloric, and combined duodenal/prepyloric ulcer disease: three distinct entities of juxtapyloric ulcer disease?
    Ström M; Bodemar G; Gotthard R; Walan A
    Scand J Gastroenterol; 1986 Nov; 21(9):1105-10. PubMed ID: 3101166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parietal cell vagotomy and truncal vagotomy in elective duodenal ulcer surgery--results after six to twelve years.
    Elfberg BA; Nilsson F; Selking O
    Ups J Med Sci; 1989; 94(2):129-36. PubMed ID: 2763389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antrectomy and gastroduodenostomy with or without vagotomy in peptic ulcer disease. A prospective study with a 5-year follow-up.
    Rehnberg O
    Acta Chir Scand Suppl; 1983; 515():1-63. PubMed ID: 6579806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease.
    Jönsson KA; Ström M; Bodemar G; Norrby K
    Scand J Gastroenterol; 1988 May; 23(4):433-41. PubMed ID: 3289111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine for recurrent ulcer after vagotomy or gastrectomy: a randomised controlled trial.
    Kennedy T; Spencer A
    Br Med J; 1978 May; 1(6122):1242-3. PubMed ID: 348251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cimetidine or vagotomy? Comparison of the effects of proximal gastric vagotomy, cimetidine and placebo on nocturnal intragastric acidity and acid secretion in patients with cimetidine resistant duodenal ulcer.
    Gledhill T; Buck M; Paul A; Hunt RH
    Br J Surg; 1983 Dec; 70(12):704-6. PubMed ID: 6640248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of proximal gastric vagotomy for duodenal ulcer resistant to cimetidine.
    Hansen JH; Knigge U
    Lancet; 1984 Jul; 2(8394):84-6. PubMed ID: 6146018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.